Clinical gastrointestinal manifestations in patients with COVID-19
DOI:
https://doi.org/10.33448/rsd-v10i13.21542Keywords:
COVID-19; Signs and Symptoms, Digestive; Gastrointestinal tract.Abstract
Objective: To identify the clinical manifestations of the gastrointestinal tract in patients affected by COVID-19 and monitored by the Municipal Health Department of Aracaju. Methodology: retrospective, cross-sectional, survey-type study, carried out from March to July 2020, based on information contained in a database of the Health Department of Aracaju. Sample composed of 3,342 patients registered in the telemonitoring program of the Department, who were tested and confirmed by RT-PCR for SARS-CoV-2. Data analyzed using percentage frequency, Pearson, Shapiro-Wilks and Mann-Whitney tests. Adopted significance level of 5%. Results and Discussion: 938 (27.36%) patients with gastrointestinal manifestations were registered: diarrhea 637 (18.58%), abdominal pain 158 (4.61%), nausea 156 (4.55%), vomiting 89 (2 .6%) and anorexia 119 (3.47%). With a mean age of 39.1 (±14.8) years, 563 (60%) were female and 930 (99.9%) lived in Aracaju or nearby. The mean age of severe cases was 55.5 (±18.9) years and 53.9% were male. The average duration of gastrointestinal symptoms was 6.5 days. All severe cases were hospitalized and, of these, 4 (0.5%) died. Main comorbidities associated with severe cases (p<0.05): cardiovascular diseases, diabetes mellitus, chronic kidney disease, cancer and neurological diseases. Conclusion: there was an important association between gastrointestinal symptoms in patients with COVID-19, especially in young and female patients. The presence of previous comorbidities was a statistically significant factor for the appearance of digestive tract manifestations.
References
Ahmed, A. O. E., Mohamed, S. F., Saleh, A. O., Al-Shokri, S. D., Ahmed, K., & Mohamed, M. F. H. (2020). Acute abdomen-like-presentation associated with SARS-CoV-2 infection. IDCases, 21, e00895. doi: 10.1016/j.idcr.2020.e00895
Ata, F., Almasri, H., Sajid, J., & Yousaf, Z. (2020). COVID-19 presenting with diarrhoea and hyponatraemia. BMJ Case Reports, 13(6), e235456. doi: 10.1136/bcr-2020-235456
Brooks, E. F., & Bhatt, A. S. (2021). The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19? Molecular Case Studies, 7(2), a006031. doi: 10.1101/mcs.a006031
D’Amico, F., Baumgart, D. C., Danese, S., & Peyrin-Biroulet, L. (2020). Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clinical Gastroenterology and Hepatology, 18(8), 1663–1672. doi: 10.1016/j.cgh.2020.04.001
Elshazli, R. M., Kline, A., Elgaml, A., Aboutaleb, M. H., Salim, M. M., Omar, M., Munshi, R., Mankowski, N., Hussein, M. H., Attia, A. S., Toraih, E. A., Settin, A., Killackey, M., Fawzy, M. S., & Kandil, E. (2021). Gastroenterology manifestations and COVID‐19 outcomes: A meta‐analysis of 25,252 cohorts among the first and second waves. Journal of Medical Virology, 93(5), 2740–2768. doi: 10.1002/jmv.26836
Freire, M; & Pattussi, M. (2018). Tipos de estudo In Estrela, C. (Org.), Metodologia Científica: Ciência, Ensino, Pesquisa (pp. 187-188). São Paulo: Editora Artes Médicas.
Fu, B., Qian, K., & Fu, X. (2020). SARS-CoV-2-Induced Vomiting as Onset Symptom in a Patient with COVID-19. Digestive Diseases and Sciences, 65(6), 1568–1570. doi: 10.1007/s10620-020-06285-4
Grossberg, L. B., Pellish, R. S., Cheifetz, A. S., & Feuerstein, J. D. (2020). Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic. Inflammatory Bowel Diseases. doi: 10.1093/ibd/izaa174
Iser, B. P. M., Sliva, I., Raymundo, V. T., Poleto, M. B., Schuelter-Trevisol, F., & Bobinski, F. (2020). Definição de caso suspeito da COVID-19: uma revisão narrativa dos sinais e sintomas mais frequentes entre os casos confirmados. Epidemiologia e Serviços de Saúde, 29(3). doi: 10.5123/s1679-49742020000300018
Kariyawasam, J. C., Jayarajah, U., Riza, R., Abeysuriya, V., & Seneviratne, S. L. (2021). Gastrointestinal manifestations in COVID-19. Transactions of The Royal Society of Tropical Medicine and Hygiene. doi: 10.1093/trstmh/trab042
Liu, J., Cui, M., Yang, T., & Yao, P. (2020). Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis. BMJ Open Gastroenterology, 7(1), e000437. doi: 10.1136/bmjgast-2020-000437
Mandal, A., Konala, V. M., Adapa, S., Naramala, S., & Gayam, V. (2020). Gastrointestinal Manifestations in COVID-19 Infection and Its Practical Applications. Cureus. doi: 10.7759/cureus.8750
Mao, R., Liang, J., Shen, J., Ghosh, S., Zhu, L.-R., Yang, H., Wu, K.-C., & Chen, M.-H. (2020). Implications of COVID-19 for patients with pre-existing digestive diseases. The Lancet Gastroenterology & Hepatology, 5(5), 425–427. doi: 10.1016/s2468-1253(20)30076-5
Menon, T., Sharma, R., Earthineni, G., Iftikhar, H., Sondhi, M., Shams, S., Khurshid Ahmed, N., Khan, H., Rathore, S. S., & Singh, R. (2021). Association of Gastrointestinal System With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis. Cureus. doi: 10.7759/cureus.13317
Poggiali, E., Ramos, P. M., Bastoni, D., Vercelli, A., & Magnacavallo, A. (2020). Abdominal Pain: A Real Challenge in Novel COVID-19 Infection. European Journal of Case Reports in Internal Medicine, 7(4). doi: 10.12890/2020_001632
Saeed, U., Sellevoll, H. B., Young, V. S., Sandbaek, G., Glomsaker, T., & Mala, T. (2020). Covid-19 may present with acute abdominal pain. British Journal of Surgery, 107(7), e186-e187. doi: 10.1002/bjs.11674
Schmulson, M., Dávalos, M. F., & Berumen, J. (2020). Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19. Revista de Gastroenterología de México, 85(3), 282–287. doi: 10.1016/j.rgmx.2020.04.001
Thevarajan, I., Buising, K. L., & Cowie, B. C. (2020). Clinical presentation and management of COVID ‐19. Medical Journal of Australia, 213(3), 134–139. doi: 10.5694/mja2.50698
Valdes, J. A. M. et al. Perforated Gastric Ulcer Related to SARS Cov-2 (COVID-19). EC Gastroenterology and Digestive System, 7(8), 144-152.
Wong, S. H., Lui, R. N., & Sung, J. J. (2020). Covid‐19 and the digestive system. Journal of Gastroenterology and Hepatology, 35(5), 744–748. doi: 10.1111/jgh.15047
Zhai, L.-L., Wang, W., Wu, L., & Tang, Z.-G. (2020). COVID-19 with abdominal symptoms and acute abdominal pain: a guide to identification for general practice. British Journal of General Practice, 70(696), 358–359. doi: 10.3399/bjgp20x710693
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Larissa Ferreira Alves da Silva; Danielle Simões Cardoso; Laryssa Fialho de Oliveira Sousa; Marianna Rodrigues Marques Dourado; Pedro Henrique Santos de Jesus; Elaine Oliveira Lima; Horley Soares Britto Neto; Mariana Sattler Lima Medina; Luísa Teixeira Silveira; Cynthia Gabrielle Sousa Rocha; Ana Regia Oliveira de Andrade; Leda Maria Delmondes Freitas Trindade
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.